KAMADA LTD (KMDA) Stock Price & Overview
NASDAQ:KMDA • IL0010941198
Current stock price
The current stock price of KMDA is 8.47 USD. Today KMDA is down by 0%. In the past month the price decreased by -6.2%. In the past year, price increased by 41.4%.
KMDA Key Statistics
- Market Cap
- 488.55M
- P/E
- 24.20
- Fwd P/E
- 17.67
- EPS (TTM)
- 0.35
- Dividend Yield
- 3.04%
KMDA Stock Performance
KMDA Stock Chart
KMDA Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to KMDA. When comparing the yearly performance of all stocks, KMDA is one of the better performing stocks in the market, outperforming 82.94% of all stocks.
KMDA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to KMDA. While KMDA has a great profitability rating, there are some minor concerns on its financial health.
KMDA Earnings
On March 11, 2026 KMDA reported an EPS of 0.06 and a revenue of 44.68M. The company missed EPS expectations (-24.1% surprise) and missed revenue expectations (-3.57% surprise).
KMDA Forecast & Estimates
9 analysts have analysed KMDA and the average price target is 12.58 USD. This implies a price increase of 48.52% is expected in the next year compared to the current price of 8.47.
For the next year, analysts expect an EPS growth of 36.97% and a revenue growth 11.28% for KMDA
KMDA Groups
Sector & Classification
KMDA Financial Highlights
Over the last trailing twelve months KMDA reported a non-GAAP Earnings per Share(EPS) of 0.35. The EPS increased by 34.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.19% | ||
| ROA | 5.33% | ||
| ROE | 7.51% | ||
| Debt/Equity | 0.04 |
KMDA Ownership
KMDA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.07 | 380.121B | ||
| AMGN | AMGEN INC | 15.24 | 190.443B | ||
| GILD | GILEAD SCIENCES INC | 15.81 | 174.171B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.63 | 113.617B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.3 | 82.171B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.73 | 43.596B | ||
| INSM | INSMED INC | N/A | 35.536B | ||
| NTRA | NATERA INC | N/A | 28.801B | ||
| BIIB | BIOGEN INC | 11.03 | 26.972B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.91 | 24.995B | ||
| MRNA | MODERNA INC | N/A | 19.759B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.548B | ||
| INCY | INCYTE CORP | 12.53 | 18.767B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About KMDA
Company Profile
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Company Info
IPO: 2005-08-01
KAMADA LTD
2 Holtzman St., Science Park
Rehovot 7670402 IL
CEO: Amir London
Employees: 393
Phone: 97289406472
KAMADA LTD / KMDA FAQ
Can you describe the business of KAMADA LTD?
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
What is the current price of KMDA stock?
The current stock price of KMDA is 8.47 USD.
Does KMDA stock pay dividends?
KAMADA LTD (KMDA) has a dividend yield of 3.04%. The yearly dividend amount is currently 0.2.
What is the ChartMill technical and fundamental rating of KMDA stock?
KMDA has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Can you provide the PE ratio for KMDA stock?
The PE ratio for KAMADA LTD (KMDA) is 24.2. This is based on the reported non-GAAP earnings per share of 0.35 and the current share price of 8.47 USD.
Who owns KAMADA LTD?
You can find the ownership structure of KAMADA LTD (KMDA) on the Ownership tab.
What is the Short Interest ratio of KAMADA LTD (KMDA) stock?
The outstanding short interest for KAMADA LTD (KMDA) is 0.44% of its float.